产品名称
Cap B, configured for ABI
type
for DNA synthesis
product line
Proligo Reagents
form
liquid
storage condition
dry at room temperature
impurities
≤200 ppm water content (Karl Fischer)
color
clear
suitability
conforms to structure (GC, Formulation)
compatibility
configured for ABI
Quality Level
正在寻找类似产品? 访问 产品对比指南
Preparation Note
四氢呋喃/N-甲基咪唑·84/16 (v/v)
General description
Cap B solution contains tetrahydrofuran (THF), pyridine, and N-methylimidazole (NMI). It is mixed in situ with Cap A solution during the capping (acetylation) reaction. Pyridine is applied as a mild base while NMI provides a powerful acylation catalyst.
Other Notes
Cap B solution, containing tetrahydrofuran (THF) and N-methylimidazole (NMI), is mixed in situ with Cap A solution during the capping (acetylation) reaction. Lutidine is applied as a mild base while NMI provides a powerful acylation catalyst.
signalword
Danger
Hazard Classifications
Acute Tox. 4 Oral - Carc. 2 - Eye Dam. 1 - Flam. Liq. 2 - Repr. 2 - Skin Corr. 1B - STOT SE 3
target_organs
Central nervous system, Respiratory system
supp_hazards
存储类别
3 - Flammable liquids
wgk
WGK 2
flash_point_f
6.1 °F
flash_point_c
-14.4 °C
法规信息
危险化学品
此项目有
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持